Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?

Title
Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
Authors
Keywords
Acne vulgaris, Ciglitazone, Cutaneous malignancy, Dioic acid, PPARs, PPAR agonists, Peroxisome proliferator-activated receptors, Pioglitazone, Psoriasis, Rosiglitazone, Scleroderma, Thiazolidinediones, Troglitazone, Zileuton
Journal
ARCHIVES OF DERMATOLOGICAL RESEARCH
Volume 307, Issue 9, Pages 767-780
Publisher
Springer Nature
Online
2015-05-18
DOI
10.1007/s00403-015-1571-1

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation